Homocysteine: Overview of Biochemistry, Molecular Biology, and Role in Disease Processes (original) (raw)

ABSTRACT

Homocysteine is derived from the essential amino acid methionine and plays a vital role in cellular homeostasis in man. Homocysteine levels depend on its synthesis, involving methionine adenosyltransferase, S-adenosylmethionine-dependent methyltransferases such as glycine N-methyltransferase, and S-adenosylhomocysteine hydrolase; its remethylation to methionine by methionine synthase, which requires methionine synthase reductase, vitamin B12, and 5-methyltetrahydrofolate produced by methylenetetrahydrofolate reductase or betaine methyltransferase; and its degradation by transsulfuration involving cystathionine β-synthase. The control of homocysteine metabolism involves changes of tissue content or inherent kinetic properties of the enzymes. In particular, S-adenosylmethionine acts as a switch between remethylation and transsulfuration through its allosteric inhibition of methylenetetrahydrofolate reductase and activation of cystathionine β-synthase. Mutant alleles of genes for these enzymes can lead to severe loss of function and varying severity of disease. Several defects lead to severe hyperhomocysteinemia, the most common form being cystathionine β-synthase deficiency, with more than a hundred reported mutations. Less severe elevations of plasma homocysteine are caused by folate and vitamin B12 deficiency, and renal disease and moderate hyperhomocysteinemia are associated with several common disease states such as cardiovascular disease. Homocysteine toxicity is likely direct or caused by disturbed levels of associated metabolites; for example, methylation reactions through elevated S-adenosylhomocysteine.

KEYWORDS

Homocysteine - enzymes - genes - inherited metabolic disorder - S-adenosylmethionine

REFERENCES

• 1 Finkelstein J D. Methionine metabolism in mammals. J Nutr Biochem. 1990; 1 228-237
• 2 Finkelstein J D. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost. 2000; 26(3) 219-225 , Review
• 3 Mudd S H, Levy H L, Kraus J P. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York; McGraw-Hill 2001: 2007-2056
• 4 Finkelstein J D. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr. 1998; 157(Suppl 2) S40-S44
• 5 Clarke S, Banfield K. S-adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobsen D Homocysteine in Health and Disease Cambridge; Cambridge University Press 2001: 63-78
• 6 Johnson J L, Duran M. Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D The Metabolic and Molecular Bases of Inherited Disease, 8th ed New York; McGraw-Hill 2001: 3163-3177
• 7 Okada G, Teraoka H, Tsukada K. Multiple species of mammalian S-adenosylmethionine synthetase. Partial purification isolation and characterisation. Biochemistry. 1981; 20 934-940
• 8 Kutzbach C, Stokstad E L. Mammalian methylenetetrahydrofolate reductase. Partial purification and inhibition by S-adenosylmethionine. Biochim Biophys Acta. 1971; 250 459-477
• 9 Konishi K, Fujioka M. Rat liver glycine methyltransferase. Cooperative binding of S-adenosylmethionine and loss of cooperativity by removal of a short NH2-terminal segment. J Biol Chem. 1988; 263 13381-13385
• 10 Rosenblatt D S, Erbe R W. Inherited disorders of folate and cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D The Metabolic and Molecular Bases of Inherited Disease, 8th ed New York; McGraw-Hill 2001 2007-2056 3897-3933
• 11 Fenton W A, Gravel R A, Rosenblatt D S. Disorders of propionate and methylmalonate metabolism. In: Scriver C, Beaudet AL, Sly WS, Valle D The Metabolic and Molecular Bases of Inherited Disease 8th ed. New York; McGraw-Hill 2001: 2165-2193
• 12 Alvarez L, Corrales F, Martin-Duce A, Mato J M. Characterization of a full-length cDNA encoding human liver S-adenosylmethionine synthetase-tissue-specific gene expression and messenger RNA levels in hepatopathies. Biochem J.. 1993; 293 481-486
• 13 Kotb M. Kredich NM: Regulation of human lymphocyte S-adenosylmethionine synthetase by product inhibition. Biochim Biophys Acta. 1990; 1039 253-260
• 14 Ubagai T, Lei K J, Huang S, Mudd S H, Levy H L, Chou J Y. Molecular mechanisms of an inborn error of methionine pathway. Methionine adenosyltransferase deficiency. J Clin Invest. 1995; 96 1943-1947
• 15 Chamberlin M E, Ubagai T, Mudd S H, Wilson W G, Leonard J V, Chou J Y. Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency. J Clin Invest. 1996; 98 1021-1027
• 16 De La Rosa J, Ostrowski J, Hryniewicz M M et al.. Chromosomal localization and catalytic properties of the recombinant alpha subunit of human lymphocyte methionine adenosyltransferase. J Biol Chem. 1995; 270 21860-21868
• 17 Horikawa S, Tsukada K. Molecular cloning and developmental expression of a human kidney S-adenosylmethionine synthetase. FEBS Lett. 1992; 312 37-41
• 18 Kim S Z, Santamaria E, Jeong T E et al.. Methionine adenosyltransferase I/III deficiency: two Korean compound heterozygous siblings with a novel mutation. J Inherit Metab Dis. 2002; 25 661-671
• 19 Mathews C K, van Holde K E. Biochemistry Redwood City, CA; Benjamin/Cummins 1990: 713
• 20 Yeo E, Wagner C. Tissue binding of glycine N-methyltransferase a major folate-binding protein of liver. Proc Natl Acad Sci USA. 1994; 91 210-214
• 21 Cantoni G L, Richards H H, Chiang P K. Inhibitors of S-adenosylhomocysteine hydrolase and their role in the regulation of biological methylation. In: Usdin E, Borchardt RT, Creveling CR Transmethylation New York; Elsevier/North-Holland 1979: 155-164
• 22 Chen Y M, Chen L Y, Wong F H, Lee C M, Chang T J, Yang-Feng T L. Genomic structure, expression, and chromosomal localization of the human glycine N-methyltransferase gene. Genomics. 2000; 66 43-47
• 23 Luka Z, Cerone R, Phillips III J A, Mudd H S, Wagner C. Mutations in human glycine N-methyltransferase give insights into its role in methionine metabolism. Hum Genet. 2002; 110 68-74
• 24 Hershfield M S, Aiyar V N, Premakumar R, Small W C. S-adenosylhomocysteine hydrolase from human placenta. Affinity purification and characterisation. Biochem J. 1985; 230 43-52
• 25 Coulter-Karis D E, Hershfield M S. Sequence of full length cDNA for human S-adenosylhomocysteine hydrolase. Ann Hum Genet. 1989; 53 169-175
• 26 Ault-Riche D B, Yuan C S, Borchardt R T. A single mutation at lysine 426 of human placental S-adenosylhomocysteine hydrolase inactivates the enzyme. J Biol Chem. 1994; 269 31472-31478
• 27 Baric I, Fumic K, Glenn B et al.. S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc Natl Acad Sci USA. 2004; 101 4234-4239
• 28 Matthews R G, Sheppard C, Goulding C. Methylenetetrahydrofolate reductase and methionine synthase: biochemistry and molecular biology. Eur J Pediatr. 1998; 157(Suppl 2) S54-S59
• 29 Utley C S, Marcell P D, Allen R H, Antony A C, Kolhouse J F. Isolation and characterization of methionine synthetase from human placenta. J Biol Chem. 1985; 260 13656-13665
• 30 Chen Z, Crippen K, Gulati S, Banerjee R. Purification and kinetic mechanism of mammalian methionine synthase from pig liver. J Biol Chem. 1994; 269 27193-27197
• 31 Hall D A, Jordan-Starck T C, Loo R O, Ludwig M L, Matthews R G. Interaction of flavodoxin with cobalamin-dependent methionine synthase. Biochemistry. 2000; 39 10711-10719
• 32 Leclerc D, Campeau E, Goyette P et al.. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet. 1996; 5 1867-1874
• 33 Li Y N, Gulati S, Baker P J, Brody L C, Banerjee R, Kruger W D. Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet. 1996; 5 1851-1858
• 34 Chen L H, Liu M L, Hwang H Y, Chen L S, Korenberg J, Shane B. Human methionine synthase. cDNA cloning, gene localization, and expression. J Biol Chem. 1997; 272 3628-3634
• 35 Watkins D, Ru M, Hwang H Y et al.. Hyperhomocysteinemia due to methionine synthase deficiency, cblG: structure of the MTR gene genotype diversity, and recognition of a common mutation, P1173L. Am J Hum Genet. 2002; 71 143-153
• 36 Leclerc D, Wilson A, Dumas R et al.. Cloning, and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA. 1998; 95 3059-3064
• 37 Leclerc D, Odievre M, Wu Q et al.. Molecular cloning, expression and physical mapping of the human methionine synthase reductase gene. Gene. 1999; 240 75-88
• 38 Olteanu H, Banerjee R. Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. J Biol Chem. 2001; 276 35558-35563
• 39 Zavadakova P, Fowler B, Zeman J, Suormala T, Pristoupilova K, Kozich V. CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families. J Inherit Metab Dis. 2002; 25 461-476
• 40 Zavadakova P, Fowler B, Suormala T et al.. CblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression. Hum Mutat. 2005; 25 239-247
• 41 Park E I, Garrow T A. Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene. J Biol Chem. 1999; 274 7816-7824
• 42 Garrow T A. Purification, kinetic properties, and cDNA cloning of mammalian betaine-homocysteine methyltransferase. J Biol Chem. 1996; 271 22831-22838
• 43 Weisberg I S, Park E, Ballman K V et al.. Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease. Atherosclerosis. 2003; 167 205-214
• 44 Daubner S C, Matthews R G. Purification and properties of methylenetetrahydrofolate reductase from pig liver. J Biol Chem. 1982; 257 140-145
• 45 Zhou J, Kang S, Wong P WK, Fournier B, Rozen R. Purification and characterisation of methylenetetrahydrofolate reductase from human cadaver liver. Biochem Med Metab Biol. 1990; 43 234-242
• 46 Jencks D A, Matthews R G. Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. J Biol Chem. 1987; 262 2485-2493
• 47 Goyette P, Sumner J S, Milos R et al.. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification. Nat Genet. 1994; 7 195-200
• 48 Goyette P, Pai A, Milos R et al.. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome. 1998; 9 652-656
• 49 Tran P, Leclerc D, Chan M et al.. Multiple transcription start sites and alternative splicing in the methylenetetrahydrofolate reductase gene result in two enzyme isoforms. Mamm Genome. 2002; 13 483-492
• 50 Sibani S, Leclerc D, Weisberg I S et al.. Characterization of mutations in severe methylenetetrahydrofolate reductase deficiency reveals an FAD-responsive mutation. Hum Mutat. 2003; 21 509-520
• 51 Tonetti C, Saudubray J M, Echenne B, Landrieu P, Giraudier S, Zittoun J. Relations between molecular and biological abnormalities in 11 families from siblings affected with methylenetetrahydrofolate reductase deficiency. Eur J Pediatr. 2003; 162 466-475
• 52 Yano H, Nakaso K, Yasui K et al.. Mutations of the MTHFR gene (428C > T and [458G > T + 459C > T]) markedly decrease MTHFR enzyme activity. Neurogenetics. 2004; 5 135-140
• 53 Suormala T, Koch H G, Rummel T, Häberle J, Fowler B. Methyltetrahyrofolate reductase (MTHFR) deficiency: mutations and functional abnormalities. J Inherit Metab Dis. 2004; 27-231
• 54 Suormala T, Gamse G, Fowler B. 5,10-Methylenetetrahydrofolate reductase (MTHFR) assay in the forward direction: residual activity in MTHFR deficiency. Clin Chem. 2002; 48 835-843
• 55 Weisberg I S, Jacques P F, Selhub J et al.. The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. R. Atherosclerosis. 2001; 156 409-415
• 56 Kraus J, Packman S, Fowler B, Rosenberg L E. Purification and properties of cystathionine β-synthase from human liver. Evidence for identical subunits. J Biol Chem. 1978; 253 6523-6528
• 57 Skovby F, Kraus J P, Rosenberg L E. Biosynthesis and proteolytic activation of cystathionine β-synthase in rat liver. J Biol Chem. 1984; 259 588-593
• 58 Kery V, Bukovska G, Kraus J P. Transsulfuration depends on heme in addition to pyridoxal 5′-phosphate-cystathionine beta-synthase is a heme protein. J Biol Chem. 1994; 269 25283-25288
• 59 Kraus J P, Le K, Swaroop M et al.. Human cystathionine beta-synthase cDNA-sequence, alternative splicing and expression in cultured cells. Hum Mol Genet. 1993; 2 1633-1638
• 60 Kraus J P. Molecular basis of phenotype expression in homocystinuria. J Inherit Metab Dis. 1994; 17 383-390
• 61 Kraus J P, Oliveriusova J, Sokolova J et al.. The human cystathionine beta-synthase (CBS) gene: complete sequence, alternative splicing, and polymorphisms. Genomics. 1998; 52 312-324
• 62 Bao L, Vlcek C, Paces V, Kraus J P. Identification and tissue distribution of human cystathionine beta-synthase mRNA isoforms. Arch Biochem Biophys. 1998; 350 95-103
• 63 Maclean K N, Janosik M, Kraus E et al.. Cystathionine beta-synthase is coordinately regulated with proliferation through a redox-sensitive mechanism in cultured human cells and Saccharomyces cerevisiae . J Cell Physiol. 2002; 192 81-92
• 64 Miles E W, Kraus J P. Cystathionine beta-synthase: structure function regulation and location of homocystinuria-causing mutations. J Biol Chem. 2004; 279 29871-29874
• 65 Heydrick S J, Weiss N, Thomas S R et al.. L-Homocysteine and L-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells. Free Radic Biol Med. 2004; 36 632-640
• 66 Jakubowski H. Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease. J Biol Chem. 2002; 277 30425-30428
• 67 Stabler S P, Marcell P D, Podell E R, Allen R H, Savage D G, Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest. 1988; 81 466-474
• 68 Ubbink J B. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia. J Inherit Metab Dis. 1997; 20 316-325
• 69 Selhub J, Jacques P F, Wilson P W, Rush D, Rosenberg I H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993; 270 2693-2698
• 70 van Ede A E, Laan R F, Blom H J et al.. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology (Oxford). 2002; 41 658-665
• 71 Badner N H, Beattie W S, Freeman D, Spence J D. Nitrous oxide-induced increased homocysteine concentrations are associated with increased postoperative myocardial ischemia in patients undergoing carotid endarterectomy. Anesth Analg. 2000; 91 1073-1079
• 72 Homocysteine Studies Collaboration . Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002; 288 2015-2022
• 73 Jacobsen D W. Cellular mechanisms of homocysteine pathogenesis in atherosclerosis. In: Carmel R, Jacobsen D Homocysteine in Health and Disease Cambridge; Cambridge University Press 2001: 425-440
• 74 Brattstrom L, Wilcken D E. Homocysteine and cardiovascular disease: cause or effect?. Am J Clin Nutr. 2000; 72 315-323

Brian FowlerPh.D.

Head of Labs/Metabolic Unit, University Children's Hospital Basel (UKBB)

Postfach CH-4005, Basel, Switzerland